에 대한 최신 뉴스 Metsera (NASDAQ:MTSR) 주식

Metsera

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

Las,Vegas,,Usa,-,April,13,,2014:,Hertz,Car,Rental

Equities

Mid Cap

News

Movers

BULL

CERT

MTSR

SBSW

VIST

ZLAB

허츠, 비스타 에너지 등 지난주 급등한 중형주 6종목 (4월 14~18일)

Metsera Inc

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21071810/Caocao-0421-900x600-1.png" alt="" class="wp-image-11065" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21071810/Caocao-0421-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21071810/Caocao-0421-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21071810/Caocao-0421-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
A Hong Kong listing by the Geely-backed ride hailing app was approved last week by the CSRC, a year after the company first filed for the IPO
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul>
<li>CaoCao's year-old effort to list in Hong Kong could be nearing completion, after receiving a green light from China's securities regulator</li>
<li>The company's revenue grew 25% in the first half of last year, outpacing its rivals, as it entered 32 new cities, boosting its footprint by more than 60%</li>
</ul>
Auto giant Geely is developing a reputation as a company that's often late to the race in the newest driving technologies and services, but then quickly makes up for lost time with its deeper resources and better execution. That could well be the case again with&nbsp;CaoCao Inc., Geely's answer to&nbsp;Uber&nbsp;(UBER.US), whose stalled IPO could finally be nearing completion.
CaoCao first filed to list in Hong Kong a year ago, but never made it to market and renewed its application last October. The Chinese securities regulator finally&nbsp;<a href="http://www.csrc.gov.cn/csrc/c105984/c7552360/content.shtml">gave the listing a green light</a>&nbsp;last Friday, clearing one of the last major regulatory hurdles. Now, CaoCao must pass its listing hearing with the Hong Kong Stock Exchange, which could happen in the next month or two, and would clear the way for it to finally become a public company.
It would join an increasingly crowded field of listed Chinese rivals, including the smaller&nbsp;Dida&nbsp;(2559.HK) and&nbsp;Chenqi&nbsp;(9680.HK). Many believe industry giant&nbsp;DiDi Global&nbsp;is also likely to list in Hong Kong in the not-too-distant future, becoming a publicly traded company again after its brief New York listing in 2021 ended due to failure to undergo a necessary data security review.
Mid-sized Chinese investment banks Huatai International, ABC International and GF Securities (Hong Kong) are underwriting the deal, which indicates it should be relatively large. Bloomberg previously reported the listing could raise several hundred million dollars.
CaoCao is a relative newcomer to China's crowded ride hailing space, founded a decade ago in 2015. The company is 84% owned by Geely founder Li Shufu, which is one of its biggest competitive advantages. Geely is one of China's most successful private automakers, with a current stable of publicly listed assets running the range from its own&nbsp;Geely&nbsp;(0175.HK) brand, to Sweden's&nbsp;Volvo&nbsp;(VOLCAR.US), electric vehicle maker&nbsp;Zeekr&nbsp;(ZKR.US), sportscar maker&nbsp;Lotus&nbsp;(LOT.US) and smart car technology maker&nbsp;ECARX&nbsp;(ECX.US).
The company distinguishes itself from rivals through increasing use of its own customized cars, which are produced by companies from the Geely family and it sells and leases to its drivers. Such a model is similar to that used by taxis, and differs from many of its rivals that simply let drivers use their own cars.
"We leverage an expanding network of battery swap stations and auto servicing shops operated by Geely Group, which empowers our drivers with significant cost advantages, enhancing their net income," CaoCao said in the most recent edition of its&nbsp;<a href="https://www1.hkexnews.hk/app/sehk/2024/106887/documents/sehk24103001734.pdf">listing document</a>&nbsp;filed last October. "Our purpose-built vehicles also optimize economics and driving experience for drivers."
The purpose-built vehicle strategy is relatively new for CaoCao, dating back to just 2022. But since then it has aggressively built up that part of the business. Such vehicles accounted for about a fifth of its gross transaction value (GTV) in 2023, and the figure rose further to 26.4% in the first half of last year. CaoCao said the ratio is expected to rise further, with an ultimate goal of providing all of its drivers with purpose-built vehicles.
<h4 class="wp-block-heading">Aggregator apps</h4>
CaoCao's other distinctive feature is its growing use of aggregation apps that offer service from many different ride hailing services. Such apps are increasingly common in China, lowering barriers of entry for smaller companies that have less resources to develop their own apps. But it has also resulted in many smaller players entering the market, ramping up the competition. Use of aggregation apps also lowers marketing costs, since most such platforms are operated by well-known names like mapping company AutoNavi and takeout dining giant Meituan.
CaoCao started out relying on its own app, but has rapidly been shifting its business onto the aggregator apps since first using them not long after its founding. Since then, the proportion of its ride-hailing orders fulfilled through aggregator apps has risen from 3.5% in 2018 to 30% in 2023. The company said it expects the ratio to keep growing to reach about half of its orders by 2028.
It pointed out the use of aggregation apps has significantly lowered its user acquisition costs, dropping them to 18.1% of its GTV in 2023 from 23.6% in 2021.
With its basic business formula in place, CaoCao has recently embarked on an aggressive expansion. It entered 32 new cities in the first half of last year alone, expanding its footprint by more than 60% to 83 cities served by last June. That helped it to record 25% revenue growth in the first half of last year, as the figure climbed to 6.16 billion yuan ($844 million) from 4.94 billion yuan a year earlier. By comparison, DiDi reported far slower 7.5% revenue growth for all last year, while Chenqi's revenue rose 14% and Dida's revenue actually fell 3.4%.
But the rapid growth also drove up CaoCao's marketing expenses to 8.4% of revenue in the first half of last year from 7.1% in 2021. It offset that partly by lowering its general and administrative and R&amp;D spending as percentage of revenue over that time.
Such efforts helped the company to record its first-ever gross profit in 2023, and the figure more than doubled to 429 million yuan in the first half of last year from 165 million yuan in the year-ago period. That lifted its gross margin to 7.0% from 5.8% over that period, and the figure looks likely to keep improving as it consolidates its position as the market's second-largest player behind only DiDi. Here, however, we should also note that CaoCao has quite a bit of catching up to do, since its listing document says the industry's top player, presumably DiDi, controlled about 75% of the market in 2023, while its own share stood at just 4.8%.
In terms of valuation, multiples are all over the map for other companies from this field. Premier names like Uber and&nbsp;Grab&nbsp;(GRAB.US) currently trade at price-to-sales (P/S) ratios of 3.7 and 5.9, respectively, while Chenqi and Dida are much lower at just 0.79 for the former and 1.25 for the latter. We expect CaoCao should be able to find a valuation closer to the premier end of that spectrum, perhaps with a P/S ratio of around 3, which would value it at a very respectable 40 billion yuan.

Asia

IPOs

Opinion

CaoCao Approaches IPO Finish Line

Stephens &amp; Co. analyst Russell Gunther maintains Synovus Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) with a Equal-Weight and lowers the price target from $52 to $46.

Price Target

Analyst Ratings

Stephens & Co. Maintains Equal-Weight on Synovus Financial, Lowers Price Target to $46

JP Morgan analyst Jeremy Tonet maintains AltaGas (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ALA#TSX">ALA</a>) with a Neutral and raises the price target from C$39 to C$41.

TSX:ALA

JP Morgan Maintains Neutral on AltaGas, Raises Price Target to C$41

Stephens &amp; Co. analyst Matt Olney maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Overweight and lowers the price target from $95 to $90.

TCBI

Stephens & Co. Maintains Overweight on Texas Capital Bancshares, Lowers Price Target to $90

3M Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) will report its <a href="https://www.benzinga.com/calendars/earnings?tickers=MMM" target="_blank" rel="noreferrer noopener">first-quarter earnings</a> on Tuesday before the market opens. Wall Street expects $1.77 in EPS and $5.76 billion in revenue as the company delivers its first quarterly update of 2025.
The stock is up 38.03% over the past year but has lost steam in recent weeks &#8211; down 1.43% year to date and a sharp 14.98% over the past month. 
Let&#8217;s look at what the charts indicate for MMM stock and how it currently compares to Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/25/04/44896269/how-to-earn-500-a-month-from-3m-stock-ahead-of-q1-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q1 Earnings</a>
<h2 class="wp-block-heading">3M Stock Bearish Ahead Of Q1 Earnings</h2>
3M stock&#8217;s technical backdrop heading into earnings is almost bearish. 3M stock, at $127.23, trades below its short and medium-term moving averages.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0421"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21105817/Screenshot-2025-04-21-at-8.27.27-PM.png" alt="" class="wp-image-879984" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21105817/Screenshot-2025-04-21-at-8.27.27-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21105817/Screenshot-2025-04-21-at-8.27.27-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0421" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
The eight-day, 20-day, and 50-day simple moving averages sit at $139.03, $140.20 and $128.86, respectively &#8211; all pointing to weakening momentum. The stock, however, sits above the 200-day average at $114.00, suggesting that longer-term bullish trends may still be intact.
The Moving Average Convergence Divergence (MACD) indicator is at 1.53, indicating bullish divergence and suggesting positive potential if earnings surprise. Meanwhile, the Relative Strength Index (RSI) reads 43.32, heading towards oversold territory. This may hint at a short-term bounce, but only if fundamentals offer a compelling narrative.
<h2 class="wp-block-heading">3M Stock Analysts See 15% Upside</h2>
Ratings &amp; Consensus Estimates: The <a href="https://www.benzinga.com/quote/MMM/analyst-ratings">consensus analyst rating</a> on MMM is a Buy, with an average price target of $138.75. The latest calls from Citigroup, Barclays, and JPMorgan place the average target even higher at $147.33, implying a 15.33% upside from current levels.
MMM Price Action: MMM stock was trading at $130.22 at the time of publication. With sentiment and technicals both deteriorating, investors will be watching closely &#8211; hoping that Tuesday's results can turn the tide and justify analysts' bullish stance.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44896337/teslas-q1-test-drive-will-earnings-steer-tesla-stock-out-of-the-ditch">Tesla Q1 Test Drive: Will Earnings Steer The Stock Out Of The Ditch?</a></li>
</ul>
Photo: Shutterstock

Technicals

Previews

Trading Ideas

3M's Chart Looks Rough, But Wall Street's Still Betting On A Bounce Ahead Of Q1 Earnings

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/04/2025-04-21_08h09_09.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Fed Independence</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-turbulent-environment-bonds-king-dollar-dxy-mc-04212025">click here</a> for an enlarged chart of the dollar index (DXY).
Note the following:
<ul>
<li>The chart also shows gold ETF SPDR Gold Trust (GLD), Japanese currency yen ETF Invesco CurrencyShares Japanese Yen Trust (FXY), SPDR S&amp;P 500 ETF Trust (SPY), and 20+ year Treasury bond ETF (TLT).</li>
<li>The chart shows that the dollar is falling.</li>
<li>The falling dollar is leading foreigners to sell bonds.&nbsp; The chart shows bond ETF TLT is falling.</li>
<li>Falling bonds are leading to a selloff in stocks in the early trade.&nbsp; The chart shows S&amp;P 500 ETF SPY is falling.</li>
<li>Investors are rushing to buy gold.&nbsp; The chart shows gold ETF GLD is rising.</li>
<li>The chart shows the Japanese yen is rising as many investors see yen as a safe haven.</li>
<li>As full disclosure, gold ETF GLD and Japanese yen ETF FXY are in our ZYX Allocation Model Portfolios.</li>
<li>The foregoing chain reaction was triggered by the Director of the National Economic Council Kevin Hassett saying that President Trump is studying how to fire Fed Chair Powell.</li>
<li>There is a serious legal question regarding the potential firing of Fed Chair Powell.</li>
<li>At this time, it is very important for investors to understand how decisions are being made in the White House and how the Supreme Court is making decisions when the administration&#8217;s actions are challenged.</li>
<li>In our analysis, if Powell is fired, this is how the markets will likely react:
<ul>
<li>The dollar may go lower.</li>
<li>Bonds may go lower.</li>
<li>Gold may go higher.</li>
<li>Japanese yen may go higher.</li>
<li>It is unclear how stocks would react.&nbsp; The reaction in the stock market will come down to who wins the battle:
<ul>
<li>Foreigners and smart money will likely be the sellers.</li>
<li>The momo crowd will likely be buying.</li>
</ul>
</li>
</ul>
</li>
<li>On the positive side, President Trump is working on several trade deals.  In our analysis, the announcement of trade deals can potentially bring significant buying into the stock market. Prudent investors should pay attention to President Trump's pain point. On April 10, we shared with you: &#8220;In our analysis, the foregoing played a role, but the real reason for the tariff reversal was likely the rise in bond yields.&#8221;</li>
</ul>
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">In our analysis, yesterday bond yields were getting close to triggering a full blown financial crisis.
</blockquote>
<ul>
<li>In our analysis, the pause in reciprocal tariffs exposed President Trump's pain point.  </li>
<li>In our analysis, prudent investors need to keep an eye on President Trump's pain point – the pain point is long bond yields spiraling towards 5%.  </li>
<li>There is a high probability that President Trump will act before the pain point is reached.</li>
<li>If President Trump decides to act, trade deals may cushion a potential drop in the stock market if Powell is fired.</li>
<li>In our analysis, prudent investors should keep in mind there is a wide range of possible outcomes.  These outcomes range from a rip roaring rally to the stock market breaking below recent lows shown on the fourth pane on the chart.  </li>
<li>Due to the popularity of Tesla Inc (TSLA) with retail investors, moves in TSLA stock impact stock market sentiment.  TSLA stock is adding to the negative sentiment in the early trade on a report that TSLA may delay a new affordable Model Y for the U.S.</li>
<li>Adding to the negative sentiment this morning is a report that Huawei is getting ready to mass ship an AI chip to compete with NVIDIA Corp (NVDA).  China is depending on Huawei to counter U.S. sanctions on Nvidia chips to China.</li>
<li>Data on leading indicators will be released at 10am ET and may be market moving. The consensus is -0.4%.</li>
<li>As an actionable item, the sum total of the foregoing is in the Arora Protection Band, which strikes the optimum balance between various crosscurrents.  </li>
<li>Any buying at this time should be considered tactical and not strategic.&nbsp; Consider using moderation for any buying.&nbsp;&nbsp;</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are negative in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), (NVDA), and (TSLA).
In the early trade, money flows are negative in S&amp;P 500 ETF (SPY) and Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.&nbsp; Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.&nbsp; The most popular ETF for gold is SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>).&nbsp; The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).&nbsp; The most popular ETF for oil is United States Oil ETF (ASCA:USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is seeing buying.
<h4 class="wp-block-heading">Arora Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  Our proprietary Protection Band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Market Summary

Broad U.S. Equity ETFs

Politics

Federal Reserve

Markets

Selling On Threat To Powell - Dollar, Stocks, And Bonds Fall; Gold And Yen Rise

Stephens &amp; Co. analyst Matt Olney maintains Bank OZK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OZK#NASDAQ">OZK</a>) with a Equal-Weight and lowers the price target from $59 to $54.

Stephens & Co. Maintains Equal-Weight on Bank OZK, Lowers Price Target to $54

Jefferies analyst Brandon Couillard maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Hold and lowers the price target from $135 to $116.

Jefferies Maintains Hold on Agilent Technologies, Lowers Price Target to $116

UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares are trading lower Monday on continued downside momentum from disappointing earnings last week. Multiple analysts also slashed price targets following the <a href="https://www.benzinga.com/general/health-care/25/04/44869920/unitedhealth-ceo-says-high-cost-of-us-health-care-simply-not-sustainable">company&#8217;s quarterly results</a>.
What Happened: UnitedHealth reported first-quarter revenue of $109.58 billion, missing analyst estimates of $111.6 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported first-quarter adjusted earnings of $7.20 per share, missing estimates of $7.29 per share.
UnitedHealth also cut its full-year 2025 outlook due to rising medical costs. The health insurer now expects full-year adjusted earnings of $26 to $26.50 per share, down from its prior outlook of $29.50 to $30 per share. Analysts had been expecting full-year earnings of $29.73 per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates.
&#8220;UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well for the years ahead, and return to our long-term earnings growth rate target of 13 to&nbsp;16%,&#8221; said Andrew Witty, CEO of UnitedHealth.
On the <a href="https://www.benzinga.com/general/health-care/25/04/44869920/unitedhealth-ceo-says-high-cost-of-us-health-care-simply-not-sustainable">conference call</a> following the print, Witty noted that health care in the U.S. is more expensive than it should be. He told investors and analysts that even common procedures can cost up to four times more in the U.S. than in other countries.
&#8220;It&#8217;s simply not sustainable,&#8221; Witty said.
Related Link: <a href="https://www.benzinga.com/trading-ideas/technicals/25/04/44898701/stock-of-the-day-where-will-the-unitedhealth-selloff-end">Stock Of The Day – Where Will The UnitedHealth Selloff End?</a>
Analyst Changes:
<ul>
<li>Oppenheimer analyst Michael Wiederhorn maintained UnitedHealth with an Outperform and lowered the price target from&nbsp;$640&nbsp;to&nbsp;$600.</li>
</ul>
<ul>
<li>Raymond James analyst John Ransom reiterated UnitedHealth with a Strong Buy and cut the price target from&nbsp;$635&nbsp;to&nbsp;$540.</li>
</ul>
<ul>
<li>Keybanc analyst Tim Rezvan maintained UnitedHealth with an Overweight and cut the price target from&nbsp;$650&nbsp;to&nbsp;$575.</li>
</ul>
<ul>
<li>Barclays analyst Andrew Mok maintained UnitedHealth with an Overweight and cut the price target from&nbsp;$642&nbsp;to&nbsp;$560.</li>
</ul>
UNH Price Action: <a href="http://benzinga.com/quote/unh">UnitedHealth Group shares</a> closed the previous trading session down 22%. The stock was down another 5.09% at $431.00 at the time of publication Monday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/JHVEPhoto">JHVEPhoto</a>/Shutterstock.

Earnings

Guidance

UnitedHealth Group Stock Is Getting Crushed: What's Fueling The Selloff?

Stephens &amp; Co. analyst Matt Olney maintains Simmons First Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFNC#NASDAQ">SFNC</a>) with a Overweight and lowers the price target from $27 to $25.

SFNC

Stephens & Co. Maintains Overweight on Simmons First Ntl, Lowers Price Target to $25

Jefferies analyst Julien Dumoulin-Smith maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Buy and raises the price target from $77 to $83.

Jefferies Maintains Buy on CMS Energy, Raises Price Target to $83

Upexi Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) stock skyrocketed on Monday after the company announced it had raised approximately $100 million through <a href="https://www.benzinga.com/pressreleases/25/04/ac44894922/upexi-announces-pricing-of-100-million-private-placement-priced-above-last-market-closing-price-u" target="_blank" rel="noreferrer noopener">securities purchase agreements</a> with a group of investors.
The deal involves the sale of 43,859,649 shares of common stock, or pre-funded warrants instead of shares, priced at $2.28 per share. 
The company plans to allocate the funds for working capital and debt reduction and establish its Solana treasury operations to expand into the cryptocurrency space.
See Also: <a href="https://www.benzinga.com/25/04/44896337/teslas-q1-test-drive-will-earnings-steer-tesla-stock-out-of-the-ditch">Tesla Q1 Test Drive: Will Earnings Steer The Stock Out Of The Ditch?</a>
The funding round saw backing from major crypto firms like Big Brain, Anagram, and Delphi Ventures and individual investors such as Austin Federa and Frank Chaparro. GSR led the investment, reinforcing support from key digital asset players.
The offering is set to close around April 24, subject to standard conditions. Funds will support Upexi&#8217;s expansion into crypto, including building a Solana treasury. About $5.3 million will be used for working capital and debt reduction.
This move aligns with Upexi&#8217;s diversification strategy, which also includes consumer product development. The private placement is being conducted under an exemption from registration requirements.
In March, Upexi&#8217;s subsidiary, Quantum Hash, agreed to <a href="https://www.benzinga.com/pressreleases/25/03/ac44075110/upexi-signs-loi-to-purchase-operating-bitcoin-mining-facility" target="_blank" rel="noreferrer noopener">acquire</a> a 2MW facility. It plans to upgrade equipment and increase mining capacity. The goal is to expand to 10-20 MW by 2025, boosting the company&#8217;s cryptocurrency portfolio and revenue potential.
Price Action: UPXI shares are trading higher by over 649% at $17.02 at last check on Monday.    
Now Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44896834/dollar-hits-3-year-lows-us-stocks-tumble-as-trump-threatens-to-fire-powell-contrarians-of-the-world-unite">Dollar Hits 3-Year Lows, US Stocks Tumble As Trump Threatens To Fire Powell: &#8216;Contrarians Of The World, Unite!</a></li>
</ul>

UPXI

Upexi Raises $100 Million To Expand Crypto Ventures, Stock Soars

Jefferies analyst Glen Santangelo maintains Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) with a Hold and lowers the price target from $10 to $8.

TDOC

Jefferies Maintains Hold on Teladoc Health, Lowers Price Target to $8

Stephens &amp; Co. analyst Terry McEvoy maintains Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) with a Overweight and lowers the price target from $26 to $24.

Stephens & Co. Maintains Overweight on Regions Finl, Lowers Price Target to $24

Ever wondered what it would be like to possess something outlandishly expensive and one-of-a kind? Maybe a <a href="https://www.artandobject.com/news/picasso-blockchain-tokenization-fillette-au-beret">Picasso</a>, <a href="https://blog.tiamonds.com/tiamonds-sets-the-bar-1-2-million-10-carat-tokenized-diamond/">a 10-carat diamond</a>, a <a href="https://www.nasdaq.com/articles/when-ferrari-tokenized-supercar-gives-european-investors-exposure-to-asset-class-2020-06">limited edition Ferrari</a>? By changing how we understand ownership, real world asset (RWA) tokenization could make the unattainable attainable.
More mundane assets like bonds and real estate are already moving into the DeFi ecosystem at speed. Figures from RWA.xyz show the market cap for tokenized RWAs hit a new <a href="https://app.rwa.xyz">all-time high of $20 billion this month</a> –&nbsp;with BlackRock's recently-launched tokenized U.S. Treasury fund (BUIDL) accounting for more than $2.5 billion.
Greater TradFi adoption seems almost certain. Is there a place for tokenized RWAs in your portfolio?
<h1 class="wp-block-heading">Understanding Tokenized RWAs</h1>
In RWA tokenization, physical assets like art, cash, real estate, or precious metals are used to create virtual investment vehicles on the blockchain.
Rather than use paper for the deed to a house or a certificate of authenticity, proofs of ownership and validity live in the decentralized finance (DeFi) ecosystem. There they can be traded between counterparties or fractionalized and put up for sale, giving many people partial ownership.
Real-world utility and ease of use are key attractions.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="497" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21094205/Screenshot-2025-04-21-at-11.41.31-1024x497.png" alt="RWA market value." class="wp-image-11071" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21094205/Screenshot-2025-04-21-at-11.41.31-1024x497.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21094205/Screenshot-2025-04-21-at-11.41.31-300x146.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21094205/Screenshot-2025-04-21-at-11.41.31-768x372.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21094205/Screenshot-2025-04-21-at-11.41.31.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">RWA Market Value Growth &#x7C; Source: RWA.xyz</figcaption></figure>
RWA tokenizing specialist Ondo Finance claims its onboarding process for retail traders can take less than five minutes — almost unheard of in technically complex DeFi. Last year its <a href="https://www.benzinga.com/quote/ondo-usd">ONDO</a> governance token grew by over 550%.
Mantra Chain aims to do the same for institutions, making the process of launching, listing, and trading RWAs compliant and similar to investing in real estate and corporate bonds. In 2024 its native <a href="https://www.benzinga.com/quote/OM-USD">OM</a> token grew 2,100%. Both companies achieved a market cap of $1 billion or more.
<h1 class="wp-block-heading">Why is RWA tokenization in the news?</h1>
Though it only captured mainstream media attention last year, tokenization has always been synonymous with blockchain.
Pritam Dutta, founder and chief executive of RWA tokenization company Zoth, told Bloomberg that "improved regulatory clarity and the approval of spot Bitcoin ETFs have boosted institutional confidence among traditional finance players."
Oh Thongsrinoon, chief marketing officer of fashion metaverse company ALTAVA, told an industry gathering in August 2024 that DeFi innovations have made tokenized assets more trustworthy and reliable.
In a <a href="https://x.com/tomwanhh/status/1812844223277707526">posting on X</a> last year, Tom Wan, a digital asset strategy associate at crypto asset manager 21.co, said decentralized autonomous organizations (DAOs) were tapping into this newfound sense of trust to diversify away from more volatile crypto assets.
DAI stablecoin issuer Sky (formerly MakerDAO) aims to leverage the trend by onboarding <a href="https://forum.makerdao.com/t/announcement-spark-tokenization-grand-prix-request-for-proposal/24631?utm_source=newsletter&amp;utm_medium=email&amp;utm_campaign=newsletter_axioscryptocurrency&amp;stream=business">up to $1 billion</a> in tokenized US Treasury bills and bonds this year. Its governance token MKR hit a three-year high last year on news of the move.
In August 2024, MKR was up over 70% year-to-date, outperforming Bitcoin by 53% for the year-to-date and Ether by 51%.&nbsp;
<h1 class="wp-block-heading">Beyond Treasuries</h1>
How will the RWA tokenization market evolve this year? ALTAVA's Thongsrinoon believes the democratization of access to previously illiquid and high-value assets means tokenized real estate, commodities, and private equity will see substantial interest.
"These asset classes offer the potential for high returns and diversification, making them attractive to both institutional clients and retail users."
Zoth's Prittam Dutta told Reuters that he expects this years' interest rate cut cycle by the US Federal Reserve to make tokenized US Treasuries less attractive due to falling yields.
This could help tokenized corporate bonds shine, he added, one reason why Zoth is set to launch a tokenized liquid note with exposure to both corporate bonds and T-bills soon.
"Corporate bonds are particularly appealing as a high-quality yield alternative in a low-interest-rate environment, especially with the Federal Reserve hinting at potential rate cuts later this year."
<h1 class="wp-block-heading">DeFi's tokenized future</h1>
From supercars to precious metals, offline-world treasures are rapidly moving on-chain, transforming how they're owned, managed and traded.&nbsp;Boston Consulting Group estimates the total value of tokenized RWAs could reach <a href="https://web-assets.bcg.com/1e/a2/5b5f2b7e42dfad2cb3113a291222/on-chain-asset-tokenization.pdf">$16 trillion by 2030</a>. Standard Chartered thinks <a href="https://www.sc.com/en/press-release/trade-finance-to-play-substantial-role-in-usd-30-1-trillion-tokenised-real-world-assets-market-by-2034/">$30 trillion</a> is possible.
In an analysis published for its 10th Digital Money Symposium, <a href="https://www.citigroup.com/global/insights/citigps/money-tokens-and-games">Citigroup said</a> tokenization presents investors with the ultimate application for cryptocurrencies and blockchain.
"Almost anything of value can be tokenized and tokenization of financial and real-world assets could be the killer use case blockchain needs to drive a breakthrough."
Crypto has long been criticized for failing to find the right product-market fit. With some of the Wall Street's biggest institutions wading in, RWA tokenization could change the narrative.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

General

RWA Tokenization Could Be Crypto's Killer App. Is There A place For It In Your Portfolio?

Stephens &amp; Co. analyst Terry McEvoy maintains Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) with a Overweight and lowers the price target from $48 to $46.

Stephens & Co. Maintains Overweight on Truist Finl, Lowers Price Target to $46

Citigroup analyst Ashwin Shirvaikar upgrades Fidelity National Info (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) from Neutral to Buy and raises the price target from $79 to $86.

Upgrades

Citigroup Upgrades Fidelity National Info to Buy, Raises Price Target to $86

Global

UAMY

United States Antimony Restarts Madero Smelter In Coahuila, Mexico On April 21, 2025, Begins Processing First International Antimony Shipment After Customs Delays, Targeting 200 Tons Monthly Production by Year-End

Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares have tumbled 40% to 78 cents in April, weighed down by weak earnings and a reduced revenue outlook despite the launch of a new hydrogen liquefaction plant.
What To Know: The <a href="https://www.benzinga.com/25/04/44875414/whats-going-on-with-plug-power-stock-today">company&#8217;s joint venture</a> with Olin Corp., Hidrogenii, began operations at a major facility in Louisiana capable of producing 15 metric tons of hydrogen daily. This brings Plug's total U.S. production capacity to 40 metric tons per day and strengthens its domestic hydrogen supply chain.
However, the stock remains under pressure following a <a href="https://www.benzinga.com/news/25/04/44614627/plug-power-stock-plagued-by-earnings-miss-cost-cuts-280m-capital-raise-in-march">disappointing fourth-quarter earnings report</a> from March, which revealed revenue of $191.5 million—well below analyst estimates—and a gross margin loss of 122%. 
The company also booked nearly $1 billion in impairment charges. In response, Plug announced cost-cutting measures through <a href="https://www.benzinga.com/25/03/44103584/plug-stock-drops-as-hydrogen-leader-struggles-with-margins-initiates-cost-reduction-plan">"Project Quantum Leap"</a> and raised $280 million in new capital.
While management remains optimistic, with CEO Andy Marsh opting to take half his salary in stock, investors are remaining cautious due to lingering financial uncertainty and a lowered 2025 revenue forecast.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44896834/dollar-hits-3-year-lows-us-stocks-tumble-as-trump-threatens-to-fire-powell-contrarians-of-the-world-unite">Dollar Hits 3-Year Lows, US Stocks Tumble As Trump Threatens To Fire Powell: &#8216;Contrarians Of The World, Unite!&#8217;</a>
<h2 class="wp-block-heading">How To Buy PLUG Stock</h2>
By now you're likely curious about how to participate in the market for Plug Power &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Plug Power, which is trading at $0.81 as of publishing time, $100 would buy you 123.46 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, PLUG has a 52-week high of $4.90 and a 52-week low of $0.79.

PLUG

Plug Power Stock Sinks 40% In April Amid Financial Struggles Despite Hydrogen Plant Launch

Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) with a Buy and lowers the price target from $50 to $20.

PIII

Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $20

Health Care

Press Releases

Metsera Announces Pricing of Initial Public Offering

Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters' Option to Purchase Additional Shares

Metsera to Present at TD Cowen's 45th Annual Health Care Conference

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

Ascentage Pharma Group International - American Depository Shares

Ascentage Pharma Group

ACADIA Pharmaceuticals Inc. - Common Stock

ACADIA Pharmaceuticals

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals

Alvotech

Apogee Therapeutics

Apellis Pharmaceuticals, Inc. - Common Stock

Apellis Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Beam Therapeutics

Biohaven

CG Oncology

Centessa Pharmaceuticals plc - American Depositary Shares

Centessa Pharmaceuticals

Denali Therapeutics

Amicus Therapeutics

Galapagos NV - American Depositary Shares

Galapagos

ImmunityBio

Immunovant

Janux Therapeutics

Kymera Therapeutics

Mirum Pharmaceuticals, Inc. - common stock

Mirum Pharmaceuticals

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

NewAmsterdam Pharma Company N.V. - Ordinary Shares

NewAmsterdam Pharma Co

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vericel

Veracyte

Guggenheim

B of A Securities

지난주 가장 좋은 성과를 낸 중형주는 다음과 같다.
<ol>
<li>위불(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) 주식은 <a href="https://www.benzinga.com//node/44876727" target="_blank" rel="noreferrer noopener">지난주 초 나스닥에 상장</a>되었고 주가는 119.05% 상승했다.</li>
<li>허츠 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) 주가는 99.03% 급등했다. 이는 빌 애크먼의 퍼싱 스퀘어 캐피털 매니지먼트가 수정된 13F를 제출하며 1,271만 주의 허츠 주식을 매수했다고 밝혔기 때문이다. 매입된 주식은 허츠 지분의 <a href="https://www.benzinga.com//node/44853443" target="_blank" rel="noreferrer noopener">약 4.1%을 의미한다.</a></li>
<li>멧세라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) 주가는 49.62% 상승했다. 이는 화이자(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)가 <a href="https://www.benzinga.com//node/44790653" target="_blank" rel="noreferrer noopener">다누글리프론(danuglipron) </a>개발을 중단했다는 소식에 따른 것이다.</li>
<li>비스타 에너지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIST#NYSE">VIST</a>) 주가는 35.52% 급등했다. 이는 회사가 9억 달러의 현금, 3억 달러의 후불, <a href="https://www.benzinga.com//node/44848713" target="_blank" rel="noopener">약 730만 ADS 단위</a>로 구성된 혼합 거래를 통해 페트로나스 E&amp;P 아르헨티나(Petronas E&amp;P Argentina)를 인수했다고 발표한 이후다.</li>
<li>시바니 스틸워터(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) 주가는 27.76% 상승했다. 이는 아마도 금 가격이 3,300달러를 넘어 사상 최고치로 나아가는 랠리와 관련이 있다.</li>
<li>방코 마크로(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMA#NYSE">BMA</a>) 주가는 27.71% 상승했다.</li>
</ol>
사진 제공: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Metsera

뉴스

에 대한 최신 뉴스 Metsera (NASDAQ:MTSR) 주식

일요일, 4월 20, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌